BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN AN OPEN-LABEL, LONG-TERM EXTENSION STUDY Taylor, P., Genovese, M., Keystone, E., Schlichting, D., Beattie, S., Macias, W. BMJ PUBLISHING GROUP. 2014: A31

View details for DOI 10.1136/annrheumdis-2013-205124.71

View details for Web of Science ID 000346248400072